Navigation Links
Red pandas reveal an unexpected (artificial) sweet tooth
Date:4/15/2009

PHILADELPHIA (April 15, 2009) -- Researchers from the Monell Center report that the red panda is the first non-primate mammal to display a liking for the artificial sweetener aspartame. This unexpected affinity for an artificial sweetener may reflect structural variation in the red panda's sweet taste receptor.

The findings may shed light on how taste preferences and diet choice are shaped by molecular differences in taste receptors.

"The red panda's unique taste receptor gives us a tool to broaden our understanding of how we detect sweet taste," said the paper's senior author, Joseph G. Brand, PhD, a biophysicist at Monell. "Greater insight into why we like artificial sweeteners could eventually lead to the development of more acceptable sugar substitutes, potentially benefiting diabetics and other individuals on sugar-restricted diets."

Many species like sweet-tasting foods, but there are some exceptions. In an earlier study, Brand and Monell comparative geneticist Xia Li, PhD, reported that cats both domestic and wild can not taste sweets due to a defect in one of the genes that codes for the sweet taste receptor.

The current research extended those findings by relating sweet preferences to genetic analyses of sweet receptor structure in six related species. Like the cat, each of the species tested -- red panda, ferret, genet, meerkat, mongoose, and lion -- belongs to the Order Carnivora.

The species, although closely related, vary widely with regard to the types of foods they eat. For example, lions, like other cats, are obligate carnivores, meaning that they eat almost exclusively meat. Meerkrats are mainly insectivores, while red pandas are primarily herbivores that almost exclusively eat bamboo leaves and shoots.

By studying the structure and function of the sweet receptor gene across species and how this relates to differences in taste preferences and diet selection, the researchers see
'/>"/>

Contact: Leslie Stein
stein@monell.org
267-519-4707
Monell Chemical Senses Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Conservation International gets support from Dreamworks Animation to protect giant pandas
2. Tentacles of venom: New study reveals all octopuses are venomous
3. New method for detection of phosphoproteins reveals regulator of melanoma invasion
4. Study reveals potential to amass more carbon in eastern North American forests
5. The fragility of the worlds coral is revealed through a study of the Northwestern Hawaiian Islands
6. Frogs reveal clues about the effects of alcohol during development
7. Model tissue system reveals cellular communication via amino acids
8. Source of major health benefits in olive oil revealed
9. UW-Madison study reveals new options for people with PKU
10. Evolutionary origin of bacterial chromosomes revealed
11. New research reveals the earliest evidence for corn in the New World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... team led by St. Jude Children,s Research Hospital scientists ... the childhood eye tumor retinoblastoma. Their work also settles ... are as scrambled as the developmental pathways at work ... a particular type of cell, researchers showed that retinoblastoma ...
... recent study suggests that parasites in fish, including threatened species ... fish health than has been assumed, and could be one ... changes cause salmon mortality. It,s not just the presence ... but their numbers that can build up over years or ...
... Extinction is a focal issue among scientists, policy makers ... are thought to have disappeared are rediscovered. Yet, these ... from the National University of Singapore (NUS), University of ... 122 years, at least 351 species which are thought ...
Cached Biology News:Childhood eye tumor made up of hybrid cells with jumbled development 2Childhood eye tumor made up of hybrid cells with jumbled development 3Parasite loads an underlying cause of salmon mortality, linked to land use changes 2Rediscovery of disappeared species: Truly back from the brink? 2
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, 2015 /PRNewswire/ ... a leader in synthetic biology, today announced it has ... (OSF), the pioneering agricultural company behind the ... apple. Through the acquisition, Intrexon expands its food programs ... and convenient for consumers while providing economic benefit throughout ...
(Date:2/27/2015)... , Feb. 27, 2015 A paper ... NCATS rare-diseases portfolio " in Science Translational ... financing technique to reduce the risk associated with ... potentially unlock new levels of funding for developing ... of a unique collaboration between scientists at the ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... 27, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is ... of BNC105 in patients with metastatic renal cancer at ... Florida . The data will be presented by ... Hope Comprehensive Cancer Center in California ... new data identifies Ferritin and IL-8 as two baseline ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5
... on August 21 and Roth Capital,s 2007 New York ... ... Strategic Diagnostics,Inc. (Nasdaq: SDIX ) -- a leading ... water, agricultural, environmental and,life science applications, announced today that its ...
... BioMaxx Systems Inc. (Other,OTC: BMXSF), is pleased ... with,Alcofuel Technologies Ltd., for the provision of the ... to the engagement,letter, Alcofuel Technologies has agreed, subject ... to design and manufacture a small,scale ethanol micro-refinery ...
... Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceutical ... product candidates for the treatment,of cancer and ... Food and,Drug Administration (FDA) has granted fast ... is currently being investigated in a,pivotal Phase ...
Cached Biology Technology:Strategic Diagnostics to Present at Two Upcoming Investor Conferences 2Strategic Diagnostics to Present at Two Upcoming Investor Conferences 3Strategic Diagnostics to Present at Two Upcoming Investor Conferences 4Strategic Diagnostics to Present at Two Upcoming Investor Conferences 5BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 3
... Kit Includes: Sufficient library for 10 ... 10^9 independent sequences, -28 gIII Sequencing ... sequencing, -96 gIII Sequencing Primer (100 ... E. coli strain ER2738, Control target ...
...
... library screening, optimal siRNA transfection ... verified for each cell type ... Transfection Optimization Kit, which was ... conditions in 96 well plates, ...
Applications: Western blotting ...
Biology Products: